Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Chondrosarcoma Foundation, NORD and Inhibrx to Establish New Patient Registry/Natural History Study

    In honor of Chondrosarcoma Awareness Day we are pleased to share this announcement. BOWIE, Maryland, Feb. 6, 2022–The Chondrosarcoma CS Foundation is teaming up with the National Organization for Rare Disorders (NORD) to establish a Chondrosarcoma...

    Read Article

    Renee Lund shares the story of her wonderful brother Steve

    Hi, my name is Renee and here is our story. If you have seen the movie Ferris Bueller’s Day off, I jokingly tell people that this is the story of my life. I am the big sister to my baby brother Steve, who I nicknamed “Ferris” many years...

    Read Article

    Samantha Shares Her and Her Husband’s Struggle and Their Survival.

    In 2020, right after the covid pandemic creeped out into our world, our little family that summer found out that my husband had Conventional Chondrosarcoma Grade 2 in his pelvis. There were some signs of this prior to our E.R. visit including weight...

    Read Article

    This Sunday, February 6 is International Chondrosarcoma Awareness Day

    This Sunday, February 6 is International Chondrosarcoma Awareness Day. Please join us and support all of the Chondrosarcoma Warriors and Families who are Fighting as well as honoring those who lost their battle from this rare bone and soft tissue...

    Read Article

    Chondrosarcoma Foundation, NORD and Inhibrx to Establish New Patient Registry/Natural History Study

    BOWIE, Maryland, Feb. 1, 2022–The Chondrosarcoma CS Foundation is teaming up with the National Organization for Rare Disorders (NORD) to establish a Chondrosarcoma Patient Registry to advance research, clinical trials and improve the treatment of...

    Read Article

    C-Path and the EJP RD to Expand Global Impact and Partnership

    FOR IMMEDIATE RELEASE C-Path and the European Joint Programme on Rare Diseases to Expand Global Impact and Partnership PARIS, France and TUCSON, Ariz., U.S., February 1, 2022 — Critical Path Institute (C-Path), an independent global...

    Read Article

    Targeting the Apoptotic Pathway in Chondrosarcoma Using,Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual,Proapoptotic Receptor (DR4/DR5) Agonist

    Article Targeting the Apoptotic Pathway in Chondrosarcoma.pdf

    Read Article

    Kayla Verret: A Mother, A Wife, A Nurse, A Fighter

    Chondrosarcoma Awareness Day is just one week away on Sunday, February 6. As we approach this date, we have been posting stories about Chondrosarcoma Warriors defying the odds and winning their battle against this rare bone and soft tissue disease...

    Read Article